Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Presenter: Marc R. Dweck

June 25, 2025

Presentation NY Valves 2024

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Role of Exercise Testing in Assessment of AR

Presenter: Robert O. Bonow

June 06, 2024

Presentation NY Valves 2024

Con: Echocardiography Is Outdated –CMR Is the New Standard!

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Presenter: Aarti Patil

June 06, 2024

Presentation NY Valves 2024

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Presenter: Scott M. Chadderdon

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Asymptomatic Severe AS – A Clinician’s Perspective

Presenter: Robert O. Bonow

June 06, 2024

Video

» On Record

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

August 6, 2025

Advertisement

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Role of Exercise Testing in Assessment of AR

Con: Echocardiography Is Outdated –CMR Is the New Standard!

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Asymptomatic Severe AS – A Clinician’s Perspective

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content